| Medicare NGS | Billing and Coding: Omalizumab and biosimilar, OMLYCLO– (omalizumab-igec) (52448) | 2025-09-17 |
| Medicare NGS | Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs (52453) | 2025-09-17 |
| Medicare NGS | Billing and Coding: Eculizumab, and Biosimilars: EPYSQLI–-eculizumab-aagh, and BKEMV–-eculizumab-aeeb (54548) | 2025-09-17 |
| Medicare NGS | Billing and Coding: Incision and Drainage (I&D) of Abscess of Skin, Subcutaneous and Accessory Structures (56766) | 2025-09-17 |
| Medicare NGS | Billing and Coding: RAST Type Tests (56844) | 2025-09-17 |
| Medicare NGS | Billing and Coding: Peripheral Nerve Blocks (57452) | 2025-09-17 |
| Medicare NGS | Billing and Coding: Urodynamics (57455) | 2025-09-17 |
| Medicare NGS | Billing and Coding: Nerve Conduction Studies and Electromyography (57668) | 2025-09-17 |
| Medicare NGS | Billing and Coding: Routine Foot Care and Debridement of Nails (57759) | 2025-09-17 |
| Medicare NGS | Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound (58893) | 2025-09-17 |